Exploring the biological mechanisms of severe COVID-19 in the elderly: Insights from an aged mouse model

The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to a global health crisis. However, definitive parameters or mechan...

Full description

Saved in:
Bibliographic Details
Published inVirulence Vol. 16; no. 1; p. 2487671
Main Authors Ma, Li, Lin, Xian, Xu, Meng, Ke, Xianliang, Liu, Di, Chen, Quanjiao
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.12.2025
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to a global health crisis. However, definitive parameters or mechanisms underlying the severity of COVID-19 in elderly people remain unclear. Thus, this study seeks to elucidate the mechanism behind the increased vulnerability of elderly individuals to severe COVID-19. We employed an aged mouse model with a mouse-adapted SARS-CoV-2 strain to mimic the severe symptoms observed in elderly patients with COVID-19. Comprehensive analyses of the whole lung were performed using transcriptome and proteome sequencing, comparing data from aged and young mice. For transcriptome analysis, bulk RNA sequencing was conducted using an Illumina sequencing platform. Proteomic analysis was performed using mass spectrometry following protein extraction, digestion, and peptide labelling. We analysed the transcriptome and proteome profiles of young and aged mice and discovered that aged mice exhibited elevated baseline levels of inflammation and tissue damage repair. After SARS-CoV-2 infection, aged mice showed increased antiviral and inflammatory responses; however, these responses were weaker than those in young mice, with significant complement and coagulation cascade responses. In summary, our study demonstrates that the increased vulnerability of the elderly to severe COVID-19 may be attributed to an attenuated antiviral response and the overactivation of complement and coagulation cascades. Future research on antiviral and inflammatory responses is likely to yield treatments that reduce the severity of viral respiratory diseases in the elderly.
AbstractList The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to a global health crisis. However, definitive parameters or mechanisms underlying the severity of COVID-19 in elderly people remain unclear. Thus, this study seeks to elucidate the mechanism behind the increased vulnerability of elderly individuals to severe COVID-19. We employed an aged mouse model with a mouse-adapted SARS-CoV-2 strain to mimic the severe symptoms observed in elderly patients with COVID-19. Comprehensive analyses of the whole lung were performed using transcriptome and proteome sequencing, comparing data from aged and young mice. For transcriptome analysis, bulk RNA sequencing was conducted using an Illumina sequencing platform. Proteomic analysis was performed using mass spectrometry following protein extraction, digestion, and peptide labelling. We analysed the transcriptome and proteome profiles of young and aged mice and discovered that aged mice exhibited elevated baseline levels of inflammation and tissue damage repair. After SARS-CoV-2 infection, aged mice showed increased antiviral and inflammatory responses; however, these responses were weaker than those in young mice, with significant complement and coagulation cascade responses. In summary, our study demonstrates that the increased vulnerability of the elderly to severe COVID-19 may be attributed to an attenuated antiviral response and the overactivation of complement and coagulation cascades. Future research on antiviral and inflammatory responses is likely to yield treatments that reduce the severity of viral respiratory diseases in the elderly.
The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to a global health crisis. However, definitive parameters or mechanisms underlying the severity of COVID-19 in elderly people remain unclear. Thus, this study seeks to elucidate the mechanism behind the increased vulnerability of elderly individuals to severe COVID-19. We employed an aged mouse model with a mouse-adapted SARS-CoV-2 strain to mimic the severe symptoms observed in elderly patients with COVID-19. Comprehensive analyses of the whole lung were performed using transcriptome and proteome sequencing, comparing data from aged and young mice. For transcriptome analysis, bulk RNA sequencing was conducted using an Illumina sequencing platform. Proteomic analysis was performed using mass spectrometry following protein extraction, digestion, and peptide labelling. We analysed the transcriptome and proteome profiles of young and aged mice and discovered that aged mice exhibited elevated baseline levels of inflammation and tissue damage repair. After SARS-CoV-2 infection, aged mice showed increased antiviral and inflammatory responses; however, these responses were weaker than those in young mice, with significant complement and coagulation cascade responses. In summary, our study demonstrates that the increased vulnerability of the elderly to severe COVID-19 may be attributed to an attenuated antiviral response and the overactivation of complement and coagulation cascades. Future research on antiviral and inflammatory responses is likely to yield treatments that reduce the severity of viral respiratory diseases in the elderly.The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to a global health crisis. However, definitive parameters or mechanisms underlying the severity of COVID-19 in elderly people remain unclear. Thus, this study seeks to elucidate the mechanism behind the increased vulnerability of elderly individuals to severe COVID-19. We employed an aged mouse model with a mouse-adapted SARS-CoV-2 strain to mimic the severe symptoms observed in elderly patients with COVID-19. Comprehensive analyses of the whole lung were performed using transcriptome and proteome sequencing, comparing data from aged and young mice. For transcriptome analysis, bulk RNA sequencing was conducted using an Illumina sequencing platform. Proteomic analysis was performed using mass spectrometry following protein extraction, digestion, and peptide labelling. We analysed the transcriptome and proteome profiles of young and aged mice and discovered that aged mice exhibited elevated baseline levels of inflammation and tissue damage repair. After SARS-CoV-2 infection, aged mice showed increased antiviral and inflammatory responses; however, these responses were weaker than those in young mice, with significant complement and coagulation cascade responses. In summary, our study demonstrates that the increased vulnerability of the elderly to severe COVID-19 may be attributed to an attenuated antiviral response and the overactivation of complement and coagulation cascades. Future research on antiviral and inflammatory responses is likely to yield treatments that reduce the severity of viral respiratory diseases in the elderly.
Author Lin, Xian
Liu, Di
Ma, Li
Ke, Xianliang
Chen, Quanjiao
Xu, Meng
Author_xml – sequence: 1
  givenname: Li
  orcidid: 0000-0002-0057-3904
  surname: Ma
  fullname: Ma, Li
– sequence: 2
  givenname: Xian
  surname: Lin
  fullname: Lin, Xian
– sequence: 3
  givenname: Meng
  surname: Xu
  fullname: Xu, Meng
– sequence: 4
  givenname: Xianliang
  surname: Ke
  fullname: Ke, Xianliang
– sequence: 5
  givenname: Di
  orcidid: 0000-0003-3693-2726
  surname: Liu
  fullname: Liu, Di
– sequence: 6
  givenname: Quanjiao
  orcidid: 0000-0001-8716-6510
  surname: Chen
  fullname: Chen, Quanjiao
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40228062$$D View this record in MEDLINE/PubMed
BookMark eNpVks1uGyEUhVGVqkndPEIrlt3Y4WcYoJuqctPWUqRs2m4Rw9yZIWIGF8ZR8vbFsR0lLABdzv2OgPMenU1xAoQ-UrKiRJErRgURQlcrRphYsUrJWtI36GJfX4qaqLPTvojO0WXOd6SMStHS9g6dV4QxRWp2gYbrh22IyU89ngfAjY8h9t7ZgEdwg518HjOOHc5wDwnw-vbv5vuSauynJz2EFlJ4_II3U_b9MGfcpThiO2HbQ4vHuMtQ5hbCB_S2syHD5XFdoD8_rn-vfy1vbn9u1t9ulq5ial5a2TiqZc117TordAtUtbUllAuuZCd5w62tdCNaxSghQGvNLbGUgRRUtpov0ObAbaO9M9vkR5seTbTePBVi6o1Ns3cBDJFgmeRUU-sq1WndNEow1nHteEs1K6yvB9Z214zQOpjmZMMr6OuTyQ-mj_eGMkJERWUhfD4SUvy3gzyb0WcHIdgJytuYYk44F6rcb4E-vTR7djn9VRGIg8ClmHOC7llCidnHwpxiYfaxMMdY8P-jd6hC
Cites_doi 10.3389/fimmu.2021.714511
10.1001/jamanetworkopen.2023.47318
10.1101/gr.1239303
10.1128/JVI.00964-21
10.1111/jth.14768
10.1126/science.abd7672
10.1126/sciimmunol.abg0833
10.1093/nar/gkv007
10.1111/jth.14817
10.1186/s13059-014-0550-8
10.1038/s41586-019-1365-2
10.1016/S2352-3026(20)30145-9
10.1016/S0140-6736(20)30211-7
10.1126/sciimmunol.abh2259
10.1089/omi.2011.0118
10.1016/j.vaccine.2024.01.082
10.3389/fimmu.2020.01661
10.1128/mBio.01753-18
10.1038/s41426-018-0063-8
10.1016/S0140-6736(20)30183-5
10.1186/s40001-020-00432-3
10.1007/BF03324904
10.1001/jamainternmed.2020.0994
10.1159/000512592
10.1038/s41467-019-09234-6
10.1001/jama.2020.2648
10.1038/s41574-018-0059-4
10.1016/j.chom.2020.05.020
10.1016/j.isci.2021.103215
10.1172/jci.insight.140711
10.1007/s13238-020-00767-x
10.1016/j.ebiom.2021.103381
10.1128/JVI.00127-09
10.1038/ni.1923
10.1080/22221751.2022.2026741
10.1093/bioinformatics/btt656
10.3389/fimmu.2022.821664
10.3390/cells10030708
10.3389/fragi.2022.900028
10.1038/s41467-021-27717-3
10.1093/gigascience/giab008
10.3389/fragi.2022.840827
10.1038/s41586-024-07238-x
10.3389/fimmu.2021.668725
10.1038/s43587-021-00114-7
10.1016/B978-012369454-6/50074-1
10.1128/JVI.01511-21
10.2215/CJN.06230614
10.1016/j.ajic.2020.06.213
10.1093/bioinformatics/btv300
10.3389/fimmu.2021.738073
10.1038/nmeth.3317
10.1101/2024.09.24.614691
10.1016/j.blre.2022.100995
10.1371/journal.pbio.3001284
10.1038/s41591-020-0822-7
10.1371/journal.pone.0247060
10.1126/science.abb8001
10.1093/bioinformatics/bty560
10.1016/j.exger.2019.110632
10.1371/journal.pone.0241824
10.1056/NEJMra0801082
10.1002/jmv.26183
10.3389/fimmu.2022.902206
10.4110/in.2019.19.e37
10.2807/1560-7917.ES.2020.25.26.2001214
10.1038/s41591-022-02156-9
10.3390/vaccines11010047
10.1093/bioinformatics/btw313
ContentType Journal Article
Copyright 2025 Chinese Academy of science. Published by Informa UK Limited, trading as Taylor & Francis Group. 2025 Chinese Academy of science
Copyright_xml – notice: 2025 Chinese Academy of science. Published by Informa UK Limited, trading as Taylor & Francis Group. 2025 Chinese Academy of science
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1080/21505594.2025.2487671
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate L. MA ET AL
EISSN 2150-5608
ExternalDocumentID oai_doaj_org_article_07ea273191ac48f99bb8522f39c3d192
PMC12005417
40228062
10_1080_21505594_2025_2487671
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0YH
53G
AAYXX
ABDBF
ABPEM
ACGFS
ACUHS
ADBBV
ADCVX
AENEX
AIJEM
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
EBS
EMOBN
ESX
F5P
GROUPED_DOAJ
GTTXZ
H13
HZ~
O9-
OK1
RPM
SV3
TDBHL
TFL
TFW
TR2
TUS
4.4
ABCCY
C1A
CGR
CUY
CVF
DGEBU
DIK
ECM
EIF
EJD
HYE
M4Z
NPM
OVD
TEORI
TTHFI
7X8
5PM
ID FETCH-LOGICAL-c428t-a7bc1976396cfa59de18d6a0135387f73b3aa49b5d82100e1693a0a12e7517d93
IEDL.DBID DOA
ISSN 2150-5594
2150-5608
IngestDate Wed Aug 27 01:22:45 EDT 2025
Thu Aug 21 18:29:09 EDT 2025
Wed Jul 02 04:58:14 EDT 2025
Wed Aug 06 16:36:22 EDT 2025
Tue Jul 01 05:05:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords complement activation
SARS-CoV-2
immune response
transcriptome
aged mice
proteome
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c428t-a7bc1976396cfa59de18d6a0135387f73b3aa49b5d82100e1693a0a12e7517d93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ORCID 0000-0003-3693-2726
0000-0002-0057-3904
0000-0001-8716-6510
OpenAccessLink https://doaj.org/article/07ea273191ac48f99bb8522f39c3d192
PMID 40228062
PQID 3190335801
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_07ea273191ac48f99bb8522f39c3d192
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12005417
proquest_miscellaneous_3190335801
pubmed_primary_40228062
crossref_primary_10_1080_21505594_2025_2487671
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-12-00
PublicationDateYYYYMMDD 2025-12-01
PublicationDate_xml – month: 12
  year: 2025
  text: 2025-12-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Virulence
PublicationTitleAlternate Virulence
PublicationYear 2025
Publisher Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Group
References Kim D (e_1_3_7_34_1) 2015; 12
Vestergaard LS (e_1_3_7_14_1) 2020; 25
e_1_3_7_41_1
e_1_3_7_66_1
e_1_3_7_45_1
e_1_3_7_64_1
e_1_3_7_22_1
e_1_3_7_24_1
e_1_3_7_49_1
Ali YM (e_1_3_7_62_1) 2021; 12
Sun SH (e_1_3_7_25_1) 2020; 28
e_1_3_7_26_1
Alosaimi B (e_1_3_7_63_1) 2021; 12
e_1_3_7_28_1
Chen S (e_1_3_7_33_1) 2018; 34
Franceschi C (e_1_3_7_47_1) 2018; 14
e_1_3_7_70_1
Ross JB (e_1_3_7_53_1) 2024; 628
e_1_3_7_30_1
e_1_3_7_72_1
Flurkey K (e_1_3_7_32_1) 2007
e_1_3_7_55_1
e_1_3_7_11_1
e_1_3_7_13_1
e_1_3_7_36_1
Campisi J (e_1_3_7_48_1) 2019; 571
Huang C (e_1_3_7_57_1) 2020; 395
e_1_3_7_38_1
Dong W (e_1_3_7_6_1) 2022; 96
e_1_3_7_19_1
e_1_3_7_2_1
e_1_3_7_4_1
Ma L (e_1_3_7_60_1) 2021; 6
Liu MY (e_1_3_7_16_1) 2020; 6
e_1_3_7_8_1
Zhou Y (e_1_3_7_44_1) 2019; 10
Bajgain KT (e_1_3_7_51_1) 2021; 49
e_1_3_7_40_1
e_1_3_7_61_1
Java A (e_1_3_7_71_1) 2020; 5
Russell CD (e_1_3_7_9_1) 2023; 29
e_1_3_7_21_1
e_1_3_7_67_1
e_1_3_7_27_1
e_1_3_7_46_1
Lim EHT (e_1_3_7_68_1) 2023; 57
e_1_3_7_29_1
Furie B (e_1_3_7_54_1) 2008; 359
Tang N (e_1_3_7_59_1) 2020; 18
Laxminarayan R (e_1_3_7_7_1) 2020; 370
Maeda M (e_1_3_7_69_1) 2024; 42
Feng E (e_1_3_7_18_1) 2021; 10
Grubeck-Loebenstein B (e_1_3_7_23_1) 2009; 21
Walter W (e_1_3_7_42_1) 2015; 31
Shannon P (e_1_3_7_43_1) 2003; 13
Jiang Y (e_1_3_7_65_1) 2018; 7
e_1_3_7_52_1
e_1_3_7_50_1
e_1_3_7_10_1
Oh SJ (e_1_3_7_20_1) 2019; 19
e_1_3_7_31_1
e_1_3_7_56_1
e_1_3_7_12_1
e_1_3_7_35_1
Kim YI (e_1_3_7_15_1) 2022; 13
e_1_3_7_58_1
e_1_3_7_39_1
e_1_3_7_3_1
e_1_3_7_5_1
R Core Team (e_1_3_7_37_1) 2024
Baker SA (e_1_3_7_17_1) 2021; 16
References_xml – volume: 12
  start-page: 714511
  year: 2021
  ident: e_1_3_7_62_1
  article-title: Lectin pathway mediates complement activation by SARS-CoV-2 proteins
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.714511
– ident: e_1_3_7_3_1
  doi: 10.1001/jamanetworkopen.2023.47318
– volume: 13
  start-page: 2498
  issue: 11
  year: 2003
  ident: e_1_3_7_43_1
  article-title: Cytoscape: a software environment for integrated models of biomolecular interaction networks
  publication-title: Genome Res
  doi: 10.1101/gr.1239303
– volume: 96
  start-page: e0096421
  issue: 1
  year: 2022
  ident: e_1_3_7_6_1
  article-title: The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus
  publication-title: J Virol
  doi: 10.1128/JVI.00964-21
– ident: e_1_3_7_56_1
  doi: 10.1111/jth.14768
– volume: 370
  start-page: 691
  issue: 6517
  year: 2020
  ident: e_1_3_7_7_1
  article-title: Epidemiology and transmission dynamics of COVID-19 in two Indian states
  publication-title: Science
  doi: 10.1126/science.abd7672
– ident: e_1_3_7_67_1
  doi: 10.1126/sciimmunol.abg0833
– ident: e_1_3_7_39_1
  doi: 10.1093/nar/gkv007
– volume: 18
  start-page: 1094
  issue: 5
  year: 2020
  ident: e_1_3_7_59_1
  article-title: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.14817
– ident: e_1_3_7_38_1
  doi: 10.1186/s13059-014-0550-8
– volume: 571
  start-page: 183
  issue: 7764
  year: 2019
  ident: e_1_3_7_48_1
  article-title: From discoveries in ageing research to therapeutics for healthy ageing
  publication-title: Nature
  doi: 10.1038/s41586-019-1365-2
– ident: e_1_3_7_55_1
  doi: 10.1016/S2352-3026(20)30145-9
– ident: e_1_3_7_58_1
  doi: 10.1016/S0140-6736(20)30211-7
– volume: 6
  start-page: eabh2259
  issue: 59
  year: 2021
  ident: e_1_3_7_60_1
  article-title: Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection
  publication-title: Sci Immunol
  doi: 10.1126/sciimmunol.abh2259
– ident: e_1_3_7_41_1
  doi: 10.1089/omi.2011.0118
– volume: 6
  start-page: 98
  issue: 2
  year: 2020
  ident: e_1_3_7_16_1
  article-title: Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
  publication-title: Chronic Dis Transl Med
– volume: 42
  start-page: 1542
  issue: 7
  year: 2024
  ident: e_1_3_7_69_1
  article-title: The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: the vaccine effectiveness, networking, and universal safety (VENUS) study
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2024.01.082
– ident: e_1_3_7_70_1
  doi: 10.3389/fimmu.2020.01661
– ident: e_1_3_7_66_1
  doi: 10.1128/mBio.01753-18
– volume: 7
  start-page: 77
  issue: 1
  year: 2018
  ident: e_1_3_7_65_1
  article-title: Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV
  publication-title: Emerg Microbes Infect
  doi: 10.1038/s41426-018-0063-8
– volume: 395
  start-page: 497
  issue: 10223
  year: 2020
  ident: e_1_3_7_57_1
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
– ident: e_1_3_7_4_1
  doi: 10.1186/s40001-020-00432-3
– volume-title: R: A language and environment for statistical computing
  year: 2024
  ident: e_1_3_7_37_1
– volume: 21
  start-page: 201
  issue: 3
  year: 2009
  ident: e_1_3_7_23_1
  article-title: Immunosenescence and vaccine failure in the elderly
  publication-title: Aging Clin Exp Res
  doi: 10.1007/BF03324904
– ident: e_1_3_7_50_1
  doi: 10.1001/jamainternmed.2020.0994
– ident: e_1_3_7_8_1
  doi: 10.1159/000512592
– volume: 10
  start-page: 1523
  issue: 1
  year: 2019
  ident: e_1_3_7_44_1
  article-title: Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-09234-6
– ident: e_1_3_7_11_1
  doi: 10.1001/jama.2020.2648
– volume: 14
  start-page: 576
  issue: 10
  year: 2018
  ident: e_1_3_7_47_1
  article-title: Inflammaging: a new immune-metabolic viewpoint for age-related diseases
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/s41574-018-0059-4
– volume: 28
  start-page: 124
  issue: 1
  year: 2020
  ident: e_1_3_7_25_1
  article-title: A mouse model of SARS-CoV-2 infection and pathogenesis
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.05.020
– ident: e_1_3_7_61_1
  doi: 10.1016/j.isci.2021.103215
– volume: 5
  start-page: e140711
  issue: 15
  year: 2020
  ident: e_1_3_7_71_1
  article-title: The complement system in COVID-19: friend and foe?
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.140711
– ident: e_1_3_7_28_1
  doi: 10.1007/s13238-020-00767-x
– ident: e_1_3_7_31_1
  doi: 10.1016/j.ebiom.2021.103381
– ident: e_1_3_7_64_1
  doi: 10.1128/JVI.00127-09
– ident: e_1_3_7_46_1
  doi: 10.1038/ni.1923
– ident: e_1_3_7_26_1
  doi: 10.1080/22221751.2022.2026741
– ident: e_1_3_7_36_1
  doi: 10.1093/bioinformatics/btt656
– ident: e_1_3_7_29_1
  doi: 10.3389/fimmu.2022.821664
– volume: 10
  start-page: 708
  issue: 3
  year: 2021
  ident: e_1_3_7_18_1
  article-title: Aging and interferons: impacts on inflammation and viral disease outcomes
  publication-title: Cells
  doi: 10.3390/cells10030708
– ident: e_1_3_7_22_1
  doi: 10.3389/fragi.2022.900028
– volume: 13
  start-page: 21
  issue: 1
  year: 2022
  ident: e_1_3_7_15_1
  article-title: Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-27717-3
– ident: e_1_3_7_35_1
  doi: 10.1093/gigascience/giab008
– ident: e_1_3_7_19_1
  doi: 10.3389/fragi.2022.840827
– volume: 628
  start-page: 162
  issue: 8006
  year: 2024
  ident: e_1_3_7_53_1
  article-title: Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity
  publication-title: Nature
  doi: 10.1038/s41586-024-07238-x
– volume: 12
  start-page: 668725
  year: 2021
  ident: e_1_3_7_63_1
  article-title: Complement anaphylatoxins and inflammatory cytokines as prognostic markers for COVID-19 severity and In-hospital mortality
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.668725
– ident: e_1_3_7_49_1
  doi: 10.1038/s43587-021-00114-7
– start-page: 637
  volume-title: The mouse in biomedical research
  year: 2007
  ident: e_1_3_7_32_1
  doi: 10.1016/B978-012369454-6/50074-1
– ident: e_1_3_7_24_1
  doi: 10.1128/JVI.01511-21
– ident: e_1_3_7_45_1
  doi: 10.2215/CJN.06230614
– volume: 49
  start-page: 238
  issue: 2
  year: 2021
  ident: e_1_3_7_51_1
  article-title: Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2020.06.213
– volume: 31
  start-page: 2912
  issue: 17
  year: 2015
  ident: e_1_3_7_42_1
  article-title: Goplot: an R package for visually combining expression data with functional analysis
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btv300
– ident: e_1_3_7_5_1
  doi: 10.3389/fimmu.2021.738073
– volume: 12
  start-page: 357
  issue: 4
  year: 2015
  ident: e_1_3_7_34_1
  article-title: HISAT: a fast spliced aligner with low memory requirements
  publication-title: Nat Methods
  doi: 10.1038/nmeth.3317
– ident: e_1_3_7_72_1
  doi: 10.1101/2024.09.24.614691
– volume: 57
  start-page: 100995
  year: 2023
  ident: e_1_3_7_68_1
  article-title: Complement activation in COVID-19 and targeted therapeutic options: a scoping review
  publication-title: Blood Rev
  doi: 10.1016/j.blre.2022.100995
– ident: e_1_3_7_27_1
  doi: 10.1371/journal.pbio.3001284
– ident: e_1_3_7_12_1
  doi: 10.1038/s41591-020-0822-7
– volume: 16
  start-page: e0247060
  issue: 2
  year: 2021
  ident: e_1_3_7_17_1
  article-title: Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0247060
– ident: e_1_3_7_13_1
  doi: 10.1126/science.abb8001
– volume: 34
  start-page: i884
  issue: 17
  year: 2018
  ident: e_1_3_7_33_1
  article-title: Fastp: an ultra-fast all-in-one FASTQ preprocessor
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bty560
– ident: e_1_3_7_21_1
  doi: 10.1016/j.exger.2019.110632
– ident: e_1_3_7_52_1
  doi: 10.1371/journal.pone.0241824
– volume: 359
  start-page: 938
  issue: 9
  year: 2008
  ident: e_1_3_7_54_1
  article-title: Mechanisms of thrombus formation
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra0801082
– ident: e_1_3_7_10_1
  doi: 10.1002/jmv.26183
– ident: e_1_3_7_2_1
  doi: 10.3389/fimmu.2022.902206
– volume: 19
  start-page: e37
  issue: 6
  year: 2019
  ident: e_1_3_7_20_1
  article-title: Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity
  publication-title: Immune Netw
  doi: 10.4110/in.2019.19.e37
– volume: 25
  start-page: 2001214
  issue: 26
  year: 2020
  ident: e_1_3_7_14_1
  article-title: Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020
  publication-title: Euro Surveill
  doi: 10.2807/1560-7917.ES.2020.25.26.2001214
– volume: 29
  start-page: 334
  issue: 2
  year: 2023
  ident: e_1_3_7_9_1
  article-title: Comorbidities, multimorbidity and COVID-19
  publication-title: Nat Med
  doi: 10.1038/s41591-022-02156-9
– ident: e_1_3_7_30_1
  doi: 10.3390/vaccines11010047
– ident: e_1_3_7_40_1
  doi: 10.1093/bioinformatics/btw313
SSID ssj0000481055
Score 2.3898478
Snippet The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 2487671
SubjectTerms Age Factors
Aged
aged mice
Aging
Animals
complement activation
COVID-19 - immunology
COVID-19 - pathology
COVID-19 - virology
Disease Models, Animal
Female
Gene Expression Profiling
Humans
immune response
Lung - immunology
Lung - pathology
Lung - virology
Male
Mice
Mice, Inbred C57BL
Proteome
Proteomics
SARS-CoV-2
SARS-CoV-2 - pathogenicity
Transcriptome
Title Exploring the biological mechanisms of severe COVID-19 in the elderly: Insights from an aged mouse model
URI https://www.ncbi.nlm.nih.gov/pubmed/40228062
https://www.proquest.com/docview/3190335801
https://pubmed.ncbi.nlm.nih.gov/PMC12005417
https://doaj.org/article/07ea273191ac48f99bb8522f39c3d192
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS8MwEA86EHwRv50fI4Kv3ZombRrfdDo2QX1xMp9K2qQ4cJ2s82H_vXdtN1YRfPE1TUi4S3O_S-5-R8gVQAQDwFw7yCXmCJkKR2MWiGHCKmT8UgzznR-fgv5QPIz80VqpL4wJK-mBS8F1XGk1mFhwK3QiwlSpOA4BM6RcJdwAPMHTF2zemjNVnMEixMqPWFkOEI8DsFks03dCt4Nt2ATuoee3PcDsgWQ1w1Tw9_8GOn_GTq4Zo94u2alQJL0pV79HNmy2T7bKupKLA_K-iqyjgO9oSbSE2qATi5m-43yS02lKwSramaXd59fBncMUHWdFf4uVuz8W13SQ5ei75xSTUKjOKBw-huJlgaVFCZ1DMuzdv3T7TlVSwUnAz5g7WsYJAwTCVZCk2lfGstAE2sXqF6FMJY-51kLFvgnBF3QtUrVoVzPPSp9Jo_gRaWTTzJ4QypTlifRjLj18E4aDgDPBTOAlxpeulU3SXsoz-iyZMyJWEZIuFRChAqJKAU1yi1JfdUbi66IBtkNUbYfor-3QJJdLnUXwo-Drh84syCWCMS7HR1-Y6LjU4WoqUbACBTA6rGm3tpb6l2z8XpBxM7yWE0ye_sfqz8g2SqQMlzknjfnsy14A6JnHLbLpvvVbxS7_Bp1t-Ck
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploring+the+biological+mechanisms+of+severe+COVID-19+in+the+elderly%3A+Insights+from+an+aged+mouse+model&rft.jtitle=Virulence&rft.au=Ma%2C+Li&rft.au=Lin%2C+Xian&rft.au=Xu%2C+Meng&rft.au=Ke%2C+Xianliang&rft.date=2025-12-01&rft.issn=2150-5608&rft.eissn=2150-5608&rft.volume=16&rft.issue=1&rft.spage=2487671&rft_id=info:doi/10.1080%2F21505594.2025.2487671&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2150-5594&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2150-5594&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2150-5594&client=summon